B Acute Lymphoblastic Leukemia With Pax5 P80r Mutation C5855498
A genetic subtype of acute lymphoblastic leukemia involving mutations in the PAX5 gene, which affects normal B-cell development. Treatment involves multi-drug chemotherapy regimens. Outcomes vary based on additional genetic factors.
Key facts at a glance
- ICD-10
- C80.1
- ICD-11
- 2A00.0
- Body system
- oncologic
- Severity
- critical
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Generalized symptoms
Symptoms may be severe and require urgent medical attention.
Seek immediate emergency care if symptoms are severe or worsening rapidly.
Pallor
(hemic)Fever
(general)Hepatosplenomegaly
(abdominal)Petechiae
(integumentary)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Risk-adapted multi-agent chemotherapy
Stratified chemotherapy protocols based on genetic risk factors including PAX5 mutation status, with more intensive regimens for high-risk presentations. Combines agents like dexamethasone, methotrexate, and 6-mercaptopurine.
Standard interventional procedure protocol
Requires immediate emergency medical intervention. Do not delay treatment.
Additional treatment options
CAR-T cell therapy
Autologous T cells engineered to target CD19 antigens on B-cell leukemic cells, infused after lymphodepleting chemotherapy. Represents a novel cellular immunotherapy approach for relapsed or refractory disease.
procedureTyrosine kinase inhibitor therapy
For Philadelphia chromosome-positive variants, BCR-ABL inhibitors like dasatinib or ponatinib may be incorporated into treatment protocols, targeting the specific genetic abnormality driving leukemogenesis.
medicationIntegrative supportive care
Complementary therapies including acupuncture for symptom management, massage for quality of life, and herbal supplements evaluated for safety alongside conventional treatment.
complementaryIntensive supportive care and infection prophylaxis
Aggressive monitoring and prevention of treatment complications including bacterial, fungal, and viral infections, along with transfusion support and nutritional intervention during neutropenic periods.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Call emergency services (911) immediately
Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.
Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.
Frequently asked questions
Common questions about this topic.
What is B Acute Lymphoblastic Leukemia With Pax5 P80r Mutation C5855498?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Schmidt M, Brady A, Lee C. Pax5 Genetic Alterations in B-Cell Acute Lymphoblastic Leukemia: Current Understanding and Clinical Implications. Blood Rev. 2022.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Acute Lymphoblastic Leukemia. Version 3.2023. J Natl Compr Canc Netw. 2023.
Patel U, Kumar R, Chen J, Anderson W. Genomic Characterization of Pax5 Mutations in Adult B-ALL: Prognostic Significance and Therapeutic Implications. Leukemia. 2021.
Zhang H, Rodriguez M, Kim S. Molecular Pathogenesis of B-Cell Acute Lymphoblastic Leukemia: Focus on Transcription Factor Dysregulation. Haematologica. 2020.
Medication Comparisons
Compare medications used to treat B Acute Lymphoblastic Leukemia With Pax5 P80r Mutation C5855498. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy